: An Ancient Commensal with Weapons of a Pathogen

Overview

Journal Pathogens

Date 2021 Apr 3

PMID 33804894

Citations 82

Authors

Meysam Sarshar

Payam Behzadi

Daniela Scribano

Anna Teresa Palamara

Cecilia Ambrosi

Affiliations

Soon will be listed here.

Abstract

is regarded as a life-threatening pathogen associated with community-acquired and nosocomial infections, mainly pneumonia. The rise in the number of antibiotic-resistant strains reduces effective therapies and increases mortality. Bacterial comparative genomic studies have unraveled the innate and acquired virulence factors of These virulence factors are involved in antibiotic resistance, environmental persistence, host-pathogen interactions, and immune evasion. Studies on host-pathogen interactions revealed that evolved different mechanisms to adhere to in order to invade host respiratory cells as well as evade the host immune system. In this review, we discuss current data on genetic features and virulence factors. An emphasis is given to the players in host-pathogen interaction in the respiratory tract. In addition, we report recent investigations into host defense systems using in vitro and in vivo models, providing new insights into the innate immune response to infections. Increasing our knowledge of pathogenesis may help the development of novel therapeutic strategies based on anti-adhesive, anti-virulence, and anti-cell to cell signaling pathways drugs.

Citing Articles

Expression of bap gene in multidrug-resistant and biofilm-producing Acinetobacter baumannii clinical isolates.

Kakavan M, Gholami M, Ahanjan M, Ebrahimzadeh M, Salehian M, Roozbahani F BMC Microbiol. 2025; 25(1):108.

PMID: 40025431 PMC: 11871766. DOI: 10.1186/s12866-025-03806-x.

Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii.

Gallegos-Monterrosa R, Cid-Uribe J, Delgado-Prudencio G, Perez-Morales D, Banda M, Tellez-Galvan A J Antibiot (Tokyo). 2025; .

PMID: 39966632 DOI: 10.1038/s41429-025-00809-8.

Bacteriophage and Phage-Encoded Depolymerase Exhibit Antibacterial Activity Against K9-Type in Mouse Sepsis and Burn Skin Infection Models.

Borzilov A, Volozhantsev N, Korobova O, Kolupaeva L, Pereskokova E, Kombarova T Viruses. 2025; 17(1.

PMID: 39861859 PMC: 11768871. DOI: 10.3390/v17010070.

The periplasmic protein HslJ is the first-line of defense against oxidative stress in Acinetobacter baumannii.

Scribano D, Pasqua M, Limongi D, Nencioni L, Palamara A, Ambrosi C Biol Res. 2025; 58(1):2.

PMID: 39794876 PMC: 11724541. DOI: 10.1186/s40659-025-00584-8.

Molecular Epidemiology and Genetic Characterization of Carbapenem-Resistant Isolates from the ICU of a Tertiary Hospital in East China.

Liu L, Huang Y, Wang Y, Jiang Y, Liu K, Pei Z Infect Drug Resist. 2025; 17:5925-5945.

PMID: 39759767 PMC: 11699857. DOI: 10.2147/IDR.S491858.

References

Hamidian M, Nigro S . Emergence, molecular mechanisms and global spread of carbapenem-resistant . Microb Genom. 2019; 5(10). PMC: 6861865. DOI: 10.1099/mgen.0.000306. View

Qiu H, KuoLee R, Harris G, Chen W . High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect. 2009; 11(12):946-55. DOI: 10.1016/j.micinf.2009.06.003. View

Harding C, Kinsella R, Palmer L, Skaar E, Feldman M . Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence. PLoS Pathog. 2016; 12(1):e1005391. PMC: 4713064. DOI: 10.1371/journal.ppat.1005391. View

Galac M, Snesrud E, Lebreton F, Stam J, Julius M, Ong A . A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development. Antimicrob Agents Chemother. 2020; 64(10). PMC: 7508605. DOI: 10.1128/AAC.00840-20. View

Hassan K, Liu Q, Henderson P, Paulsen I . Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems. mBio. 2015; 6(1). PMC: 4337561. DOI: 10.1128/mBio.01982-14. View

Magnet S, Courvalin P, Lambert T . Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 2001; 45(12):3375-80. PMC: 90840. DOI: 10.1128/AAC.45.12.3375-3380.2001. View

Pires S, Peignier A, Seto J, Smyth D, Parker D . Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice. JCI Insight. 2020; 5(7). PMC: 7205275. DOI: 10.1172/jci.insight.132223. View

Kim S, Choi C, Moon D, Jin J, Lee J, Shin J . Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett. 2009; 301(2):224-31. DOI: 10.1111/j.1574-6968.2009.01820.x. View

Kamoshida G, Kikuchi-Ueda T, Nishida S, Tansho-Nagakawa S, Ubagai T, Ono Y . Pathogenic Bacterium Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion. Front Immunol. 2018; 9:178. PMC: 5808340. DOI: 10.3389/fimmu.2018.00178. View

10.

Colquhoun J, Rather P . Insights Into Mechanisms of Biofilm Formation in and Implications for Uropathogenesis. Front Cell Infect Microbiol. 2020; 10:253. PMC: 7273844. DOI: 10.3389/fcimb.2020.00253. View

11.

Iyer R, Moussa S, Durand-Reville T, Tommasi R, Miller A . Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin. ACS Infect Dis. 2017; 4(3):373-381. DOI: 10.1021/acsinfecdis.7b00168. View

12.

Rumbo C, Tomas M, Fernandez Moreira E, Soares N, Carvajal M, Santillana E . The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect Immun. 2014; 82(11):4666-80. PMC: 4249306. DOI: 10.1128/IAI.02034-14. View

13.

Ayoub Moubareck C, Hammoudi Halat D . Insights into : A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics (Basel). 2020; 9(3). PMC: 7148516. DOI: 10.3390/antibiotics9030119. View

14.

Javaheri A, Kruse T, Moonens K, Mejias-Luque R, Debraekeleer A, Asche C . Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat Microbiol. 2016; 2:16189. DOI: 10.1038/nmicrobiol.2016.189. View

15.

Lee C, Lee J, Park M, Park K, Bae I, Kim Y . Biology of : Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol. 2017; 7:55. PMC: 5346588. DOI: 10.3389/fcimb.2017.00055. View

16.

Ramos J, Gallegos M, Marques S, Ramos-Gonzalez M, Espinosa-Urgel M, Segura A . Responses of Gram-negative bacteria to certain environmental stressors. Curr Opin Microbiol. 2001; 4(2):166-71. DOI: 10.1016/s1369-5274(00)00183-1. View

17.

Dupont M, Pages J, Lafitte D, Siroy A, Bollet C . Identification of an OprD homologue in Acinetobacter baumannii. J Proteome Res. 2005; 4(6):2386-90. DOI: 10.1021/pr050143q. View

18.

Vijayakumar S, Biswas I, Veeraraghavan B . Accurate identification of clinically important spp.: an update. Future Sci OA. 2019; 5(6):FSO395. PMC: 6609899. DOI: 10.2144/fsoa-2018-0127. View

19.

Limansky A, Mussi M, Viale A . Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol. 2002; 40(12):4776-8. PMC: 154632. DOI: 10.1128/JCM.40.12.4776-4778.2002. View

20.

Agarwal S . Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol. 2014; 5:131. PMC: 4042084. DOI: 10.3389/fphar.2014.00131. View